124 related articles for article (PubMed ID: 1754987)
1. [Bismuth revisited in Helicobacter pylori gastro-duodenal infection].
Caron F; Rouveix B
Therapie; 1991; 46(5):393-8. PubMed ID: 1754987
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
3. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
May B
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
[TBL] [Abstract][Full Text] [Related]
4. Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Kung NN; Sung JJ; Yuen NW; Ng PW; Wong KC; Chung EC; Lim BH; Choi CH; Li TH; Ma HC; Kwok SP
Am J Gastroenterol; 1997 Mar; 92(3):438-41. PubMed ID: 9068464
[TBL] [Abstract][Full Text] [Related]
5. [Therapy of peptic ulcer and chronic gastritis with bismuth salts].
Rösch W
Z Gastroenterol; 1987 Sep; 25 Suppl 4():34-40. PubMed ID: 3687149
[TBL] [Abstract][Full Text] [Related]
6. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
[TBL] [Abstract][Full Text] [Related]
7. [Campylobacter pylori and therapy with bismuth salts].
Börsch G
Med Monatsschr Pharm; 1988 Sep; 11(9):301-7. PubMed ID: 3067064
[No Abstract] [Full Text] [Related]
8. Treatment of Campylobacter pylori gastritis: a pilot study using pirenzepine dihydrochloride (Gastrozepin) and three formulations of colloidal bismuth subcitrate (De-Nol).
Morris A; Brown P; Ali MR; Lane M; Palmer R
N Z Med J; 1988 Oct; 101(856 Pt 1):651-4. PubMed ID: 3054641
[TBL] [Abstract][Full Text] [Related]
9. Campylobacter pylori and its role in peptic ulcer disease.
Tytgat GN; Rauws EA
Gastroenterol Clin North Am; 1990 Mar; 19(1):183-96. PubMed ID: 2184128
[TBL] [Abstract][Full Text] [Related]
10. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
Wagstaff AJ; Benfield P; Monk JP
Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
Nijevitch AA; Farztdinov KM; Sataev VU; Khasanov RSh ; Katayev VA; Khusnutdinov SM; Akhunov ED; Kazykhanov NS
J Gastroenterol Hepatol; 2000 Nov; 15(11):1243-50. PubMed ID: 11129216
[TBL] [Abstract][Full Text] [Related]
12. [Bismuth--an environmental pollutant of the future].
Mueller RL
Zentralbl Hyg Umweltmed; 1989 Nov; 189(2):117-24. PubMed ID: 2604843
[TBL] [Abstract][Full Text] [Related]
13. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease.
Bayerdörffer E; Ottenjann R
Scand J Gastroenterol Suppl; 1988; 142():93-100. PubMed ID: 3047854
[TBL] [Abstract][Full Text] [Related]
14. Bismuth therapy in gastrointestinal diseases.
Gorbach SL
Gastroenterology; 1990 Sep; 99(3):863-75. PubMed ID: 2199292
[TBL] [Abstract][Full Text] [Related]
15. The role of Helicobacter pylori in peptic ulcer disease.
O'Connor HJ
Scand J Gastroenterol Suppl; 1994; 201():11-5. PubMed ID: 8047817
[TBL] [Abstract][Full Text] [Related]
16. Low dose, short duration therapy for the eradication of Helicobacter pylori in patients with duodenal ulcer.
Iser JH; Buttigieg RJ; Iseli A
Med J Aust; 1994 Feb; 160(4):192-6. PubMed ID: 7906009
[TBL] [Abstract][Full Text] [Related]
17. [New ultrashort scheme for helicobacter pylori infection eradication using tetracyline, furazolidone and colloidal bismuth subcitrate in dyspeptic patients with or without peptic ulceration in the National Hospital Cayetano Heredia].
Araujo Castillo R; Pinto Valdivia JL; Ramírez D; Cok García J; Bussalleu Rivera A
Rev Gastroenterol Peru; 2005; 25(1):23-41. PubMed ID: 15818420
[TBL] [Abstract][Full Text] [Related]
18. Campylobacter pylori. Diagnosis and treatment.
Tytgat GN; Rauws EA; de Koster EH
J Clin Gastroenterol; 1989; 11 Suppl 1():S49-53. PubMed ID: 2681390
[TBL] [Abstract][Full Text] [Related]
19. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of Helicobacter pylori infection: current status].
Wagner S; Gebel M; Manns M
Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
